ZNF395 facilitates macrophage polarization and impacts the prognosis of glioma

Feng Xiao1, Jie Shen2, Lihui Zhou2

  • 1Department of Neurosurgery, The 1st Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China.

Insights

Zinc Finger Protein 395 (ZNF395) is overexpressed in glioma, promoting tumor cell proliferation and M2 macrophage polarization via CCL20. Inhibiting ZNF395 may offer a new glioma therapy strategy.

Area of Science:

  • Neuro-oncology
  • Cancer immunology
  • Molecular biology

Background:

  • The tumor microenvironment significantly influences glioma development.
  • Understanding glioma's immune microenvironment mechanisms is crucial for effective therapy.

Purpose of the Study:

  • To investigate the role of Zinc Finger Protein 395 (ZNF395) in glioma.
  • To elucidate the molecular mechanisms by which ZNF395 affects glioma progression and immune infiltration.

Main Methods:

  • Analysis of patient datasets (TCGA, CGGA) to assess ZNF395 expression and correlation with clinical features.
  • In vitro experiments to evaluate ZNF395's effect on glioma cell proliferation.
  • Functional enrichment analysis to identify ZNF395-associated biological processes.
  • Validation of C-C Motif Chemokine Ligand 20 (CCL20) as a downstream target of ZNF395.
  • Co-culture experiments to assess ZNF395's impact on macrophage polarization.

Main Results:

  • ZNF395 was found to be aberrantly overexpressed in glioma, correlating with poor prognosis.
  • ZNF395 overexpression promoted glioma cell proliferation in vitro.
  • ZNF395 was linked to immune processes, macrophage infiltration, and polarization.
  • CCL20 was identified as a direct transcriptional target of ZNF395.
  • ZNF395 upregulated CCL20 in glioma cells, inducing M2 macrophage polarization.

Conclusions:

  • ZNF395 plays a significant role in glioma development and progression.
  • ZNF395 influences the glioma immune microenvironment by promoting M2 macrophage polarization through CCL20.
  • Targeting ZNF395 presents a potential therapeutic strategy for glioma.